Following ART modification, patients with HIV aged 60 years and older demonstrated significantly higher odds of experiencing ...
Bioengineer.org news story. Pulmonary TB has long been described as a disease with a signature: a cavity carved into the ...
A review argues that the world will never reach the End TB Strategy targets unless rapid, accurate testing reaches the ...
A new long-acting HIV treatment could expand options for people who have trouble taking daily pills and whose virus is ...
HIV appears to strip the immune system of its ability to recognize tumor neoepitopes without altering the tumor’s mutational ...
Health Policy Watch | US finally signs health deal with Zambia, but still pursues minerals agreement
In 2024, 84% of Zambia’s HIV programme was funded by PEPFAR – and 1.3 million Zambians are on antiretroviral medicines.
CROWN is the first large, phase IIIb trial to evaluate the investigational use of LA Cabenuva versus daily oral therapy in ...
A retrospective study reported high recent use of GLP-1 receptor agonists in people living with HIV at a UK centre, with ...
As the population of people with HIV ages, researchers studied cognitive health changes; 46% of study participants were ...
University of British Columbia news release. The HPV vaccine provides strong, long-lasting protection for women living with ...
Mirum Pharmaceuticals press release. Mirum Pharmaceuticals, Inc. announced the primary endpoint was met in the Phase 3 ...
Women with HIV have almost twice the risk of CVD compared to women without HIV, while men with HIV have a 44% increased risk ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results